Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OsteoActivator-M
- Development stage
- Preclinical
- Lead developer
- Osteo Pharma
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Administration
- Injectable
01
Overview
OsteoActivator-M (BT002) is an injectable, controlled-release drug delivery system developed by Osteopharma for the treatment of osteoarthritis, bone defects, and vertebral compression fractures. It consists of biodegradable poly(lactic-co-glycolic acid) (PLGA) microspheres that provide sustained local release of two active ingredients: testosterone and alendronate. The mechanism of action is synergistic; testosterone stimulates osteoblast activity to promote bone formation, while alendronate, a bisphosphonate, inhibits osteoclast-mediated bone resorption. This dual action shifts the bone remodeling balance toward increased new bone formation. The microspheres are designed for local injection, such as intraosseous injection into subchondral bone, and release the therapeutic agents over a 4-6 week period.
- Brand names
- OsteoActivator-M
02
Targets
AR (Adrenergic receptors)FDPS (Farnesyl pyrophosphate synthase)
Beyond the preview
Go deeper on OsteoActivator-M.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OsteoActivator-M.